NCT Number: NCT01335386
Investigation of KLYX in Patients With Constipation
This is a randomised, assessor-blind, multi-centre pilot study to investigate the comparative safety and efficacy of KLYX and glycerine enema in the symptomatic treatment of constipation in Chinese patients.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–65 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 2
Primary location
Changhai Hospital, The Second Military Medical University, Shanghai, China
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Have signed the informed consent form and have been verbally explained the details of the trial and treatment procedures
- Ethnically Chinese
- Males or females aged between 18 and 65 years inclusive
- A history of constipation symptoms for at least 6 months fulfilling, with occurrence of two or more of the following symptoms during the 3 months before screening (the 3 months need not be consecutive):
i. Very hard (pellet-like) and/or hard stools (Type 1 or 2 of the Bristol Stool Scale) for at least 25% of the time; or ii. Sensation of incomplete evacuation at least 25% of the time; or iii. Straining during defecation at least 25% of the time; or iv. Sensation of anorectal obstruction or blockage often during defecation at least 25% of the time; or v. Manual manoeuvres needed often to facilitate defecations (e.g. digital evacuation, support of the pelvic floor) at least 25% of the time; or vi. Fewer than 3 defecations per week.
- Patient has had no bowel movement (i.e. still constipated) two days prior randomisation.
Exclusion criteria
- Any disorder or laboratory result at Screening that in the judgement of the investigator that will place the subject at excessive risk if participating in a controlled study
- Clinically suspected to have colorectal cancer
- Significant gastroparesis or gastric outlet obstruction
- Hypersensitivity to sodium docusate and/or sorbitol
- Hypersensitivity to glycerine
- Pregnant or lactating women, women who intend to conceive, or women who are sexually active and capable of pregnancy who are not using a method of birth control (e.g. prescription hormonal contraceptives, intrauterine device, double-barrier method, male partner sterilization)
- Diabetic patients currently on insulin therapy
- Having participated in other clinical trial(s) within the 3 (three) months prior screening
- Unable to withdraw medications that may affect gastrointestinal motility such as prokinetics, erythromycin analogues, laxatives, etc.
- Unable to meet or perform study requirements: known or suspected inability to comply with the study protocol
Treatment and study plan
Glycerine
DrugPrimary outcomes
-
Overall efficacy of enema
Time frame: immediately following enema administration
Secondary outcomes
-
Time to first bowel movement
Time frame: Immediately following enema administration
-
Patient's overall satisfaction with enema treatment
Time frame: Immediately following enema administration
-
Stool form after enema treatment
Time frame: Immediately following enema administration
Sponsors and collaborators
Lead sponsor
Ferring Pharmaceuticals
Industry
Registry information
Official study title
Efficacy and Safety of KLYX Versus Glycerine Enema in Chinese Patients With Constipation - a Randomised, Assessor-blind Pilot Study
Important dates
- Study start
- 2010
- Primary completion
- 2010
- Study completion
- 2010
- First posted
- Apr 14, 2011
- Registry last updated
- Feb 6, 2012
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Development of a Constipation Risk Assessment Scale for Hospitalized Patients.
NCT04068415
Constipation, Pathological Conditions, Signs and Symptoms
View Trial DetailsMOWOOT Device Treatment for Adults With Chronic Constipation
NCT04666155
Constipation, Constipation - Functional
Durham, County Durham and Darlington, United Kingdom
View Trial DetailsDairy Products to Your Gut and Brain
NCT06311097
Constipation, Healthy
Copenhagen, Denmark
View Trial DetailsRadicle GI Health RDH™: A Study Assessing the Impact of Health and Wellness Products on Gastrointestinal (GI) Health and Related Health Outcomes
NCT07230821
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Del Mar, California, United States
View Trial Details